ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Auricular Acupressure for Hemodialysis Patients with Insomnia: A Multicenter Double-Blind Randomized Sham-Controlled Trial

Wu, Yuchi; Yang, Lihong; Zhong, Zhicong; Wu, Xiuqing; He, Zhiren; Ma, Hongyan; Cai, Cun; Li, Yin; Wu, Xufang; Fu, Bo; Chen, Xiaoling; Wang, Lixin; Zhao, Daixin; Meng, Xiangxin; Qi, Airong; Yang, Aicheng; Li, Lingli; Liu, Xusheng; Zou, Chuan*; Lin, Qizhan*广东省人民医院; 广州中医药大学
JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE2022-4DOI: 10.1089/jicm.2021.0332
5阅读
引用收藏
分享

摘要

Background and objectives: The effect of auricular acupressure (AA) for maintenance hemodialysis (MHD) patients with insomnia has been controversial. This study assessed the efficacy and safety of AA for MHD patients with chronic insomnia.Design, setting, participants, and measurements: This was a multicenter, double-blind (participant and assessor), randomized sham-controlled trial. A total of 133 subjects were randomized to receive AA on active points (AA group, n = 64) or on sham auricular acupressure (SAA) points (SAA group, n = 69) for 8 weeks and followed up for 12 weeks. AA was provided by assigned qualified nurses who were not involved in assessment. The primary outcome was the clinical response rate, which was defined as the percentage of participants who reached a reduction of Pittsburgh Sleep Quality Index (PSQI) global score >= 3 in each group. Secondary outcomes included changes in PSQI scores over time, PSQI scores and hypnotics use at each visit, and changes in the weekly dose of hypnotics for drug-dependent subjects.Results: At week 8, the AA group yielded a higher clinical response rate than the SAA group (AA: 55% vs. SAA: 36%, odds ratio: 1.5, 95% confidence interval: 1.0-2.2, p = 0.033). Both groups showed a reduction in PSQI global scores during treatment and follow-up, compared with the baseline, respectively. A significant change of PSQI global score was observed over time (F = 28.387, p < 0.001). PSQI global score of the AA group was relatively lower than that of the SAA group at each visit (p < 0.05 at week 16 and 20). For those depending on hypnotics, AA reduced their consumption of hypnotics. The intervention was safe, and its adherence was satisfactory.Conclusion: AA could serve as a complementary or alternative therapy for MHD patients with insomnia by improving their sleep quality and reducing their use of hypnotics.

学科与关键词

关键词
insomniahemodialysisauriculotherapyrandomized controlled trialrenal insufficiency
相关
加载中…
  • Acupuncture treatment of hypertension with insomnia A protocol for randomized, double-blind, placebo controlled trial research
    Zhu, Xun; Yan, Luda; Dou, Xuejiao; Zheng, Yanping; He, Guanglin; Liao, Meiyan; Fu, Wenbin*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2022, 101(2): e28455.
  • Effects of transcutaneous auricular vagus nerve stimulation on brain functional connectivity of medial prefrontal cortex in patients with primary insomnia
    Zhang, Shuai; He, Jia-Kai; Meng, Hong; Zhao, Bin; Zhao, Ya-Nan; Wang, Yu; Li, Shao-Yuan; Wang, Lei; Wu, Mo-Zheng; Chen, Yu; Xiao, Xue; Hou, Li-Wei; Fang, Ji-Liang; Rong, Pei-Jing*Anatomical Record, 2021, 304(11): 2426-2435.被引 14
  • Acupuncture for chemotherapy-associated insomnia in breast cancer patients: an assessor-participant blinded, randomized, sham-controlled trial
    Zhang, Jialing; Qin, Zongshi; So, Tsz Him; Chang, Tien Yee; Yang, Sichang; Chen, Haiyong; Yeung, Wing Fai; Chung, Ka Fai; Chan, Pui Yan; Huang, Yong; Xu, Shifen; Chiang, Chun Yuan; Lao, Lixing*; Zhang, Zhang-Jin*BREAST CANCER RESEARCH, 2023, 25(1): 49.被引 4
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE
发表日期
2022-04
卷期
第 28 卷, 第 4 期
页码
339-348
DOI
10.1089/jicm.2021.0332
成果收录
SCIE

作者

  • W

    Wu, Yuchi (第一作者)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • Y

    Yang, Lihong

    guangdong prov acad chinese med sci · 2 · guangzhou univ chinese med

查看全部 20 位作者收起作者
  • Z

    Zhong, Zhicong

    2 · guangdong prov hosp · guangzhou univ chinese med

  • W

    Wu, Xiuqing

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    He, Zhiren

    2 · guangzhou univ chinese med

  • M

    Ma, Hongyan

    2 · guangzhou univ chinese med

  • C

    Cai, Cun

    2 · guangzhou univ chinese med

  • L

    Li, Yin

    2 · guangzhou univ chinese med

  • W

    Wu, Xufang

  • F

    Fu, Bo

  • C

    Chen, Xiaoling

    2 · guangzhou univ chinese med

  • W

    Wang, Lixin

    2 · guangzhou univ chinese med

  • Z

    Zhao, Daixin

    2 · guangzhou univ chinese med

  • M

    Meng, Xiangxin

  • Q

    Qi, Airong

  • Y

    Yang, Aicheng

  • L

    Li, Lingli

    2 · guangzhou univ chinese med

  • L

    Liu, Xusheng

    2 · guangzhou univ chinese med

  • Z

    Zou, Chuan (通讯)

    2 · guangzhou univ chinese med

  • L

    Lin, Qizhan (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417